Ultrasound Radiomics in Personalized Breast Management: Current Status and Future Prospects

Overview

Journal Front Oncol

Specialty Oncology

Date 2022 Sep 5

PMID 36059645

Authors

Jionghui Gu

Tianan Jiang

Affiliations

Soon will be listed here.

Abstract

Breast cancer is the most common cancer in women worldwide. Providing accurate and efficient diagnosis, risk stratification and timely adjustment of treatment strategies are essential steps in achieving precision medicine before, during and after treatment. Radiomics provides image information that cannot be recognized by the naked eye through deep mining of medical images. Several studies have shown that radiomics, as a second reader of medical images, can assist physicians not only in the detection and diagnosis of breast lesions but also in the assessment of risk stratification and prediction of treatment response. Recently, more and more studies have focused on the application of ultrasound radiomics in breast management. We summarized recent research advances in ultrasound radiomics for the diagnosis of benign and malignant breast lesions, prediction of molecular subtype, assessment of lymph node status, prediction of neoadjuvant chemotherapy response, and prediction of survival. In addition, we discuss the current challenges and future prospects of ultrasound radiomics.

Citing Articles

Application of Ultrasound Radiomics in Differentiating Benign from Malignant Breast Nodules in Women with Post-Silicone Breast Augmentation.

Hao L, Chen Y, Su X, Ma B Curr Oncol. 2025; 32(1.

PMID: 39851945 PMC: 11764215. DOI: 10.3390/curroncol32010029.

Classifying the molecular subtype of breast cancer using vision transformer and convolutional neural network features.

Kai C, Tamori H, Ohtsuka T, Nara M, Yoshida A, Sato I Breast Cancer Res Treat. 2025; .

PMID: 39841349 DOI: 10.1007/s10549-025-07614-9.

Research on ultrasound-based radiomics: a bibliometric analysis.

Yu L, Che M, Wu X, Luo H Quant Imaging Med Surg. 2024; 14(7):4520-4539.

PMID: 39022291 PMC: 11250334. DOI: 10.21037/qims-23-1867.

Metallic Copper-Based Dual-Enzyme Biomimetic Nanoplatform for Mild Photothermal Enhancement of Anticancer Catalytic Activity.

Chen Z, Li Y, Xiang Q, Wu Y, Ran H, Cao Y Biomater Res. 2024; 28:0034.

PMID: 38840654 PMC: 11151172. DOI: 10.34133/bmr.0034.

A nomogram model combining ultrasound-based radiomics features and clinicopathological factors to identify germline BRCA1/2 mutation in invasive breast cancer patients.

Guo R, Yu Y, Huang Y, Lin M, Liao Y, Hu Y Heliyon. 2024; 10(1):e23383.

PMID: 38169922 PMC: 10758804. DOI: 10.1016/j.heliyon.2023.e23383.

References

DiCenzo D, Quiaoit K, Fatima K, Bhardwaj D, Sannachi L, Gangeh M . Quantitative ultrasound radiomics in predicting response to neoadjuvant chemotherapy in patients with locally advanced breast cancer: Results from multi-institutional study. Cancer Med. 2020; 9(16):5798-5806. PMC: 7433820. DOI: 10.1002/cam4.3255. View

De Faria Castro Fleury E, Marcomini K . Impact of radiomics on the breast ultrasound radiologist's clinical practice: From lumpologist to data wrangler. Eur J Radiol. 2020; 131:109197. DOI: 10.1016/j.ejrad.2020.109197. View

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

Xiong Q, Zhou X, Liu Z, Lei C, Yang C, Yang M . Multiparametric MRI-based radiomics analysis for prediction of breast cancers insensitive to neoadjuvant chemotherapy. Clin Transl Oncol. 2019; 22(1):50-59. DOI: 10.1007/s12094-019-02109-8. View

Gao Y, Luo Y, Zhao C, Xiao M, Ma L, Li W . Nomogram based on radiomics analysis of primary breast cancer ultrasound images: prediction of axillary lymph node tumor burden in patients. Eur Radiol. 2020; 31(2):928-937. DOI: 10.1007/s00330-020-07181-1. View

Li C, Li J, Tan T, Chen K, Xu Y, Wu R . Application of ultrasonic dual-mode artificially intelligent architecture in assisting radiologists with different diagnostic levels on breast masses classification. Diagn Interv Radiol. 2021; 27(3):315-322. PMC: 8136533. DOI: 10.5152/dir.2021.20018. View

Zhang X, Liang M, Yang Z, Zheng C, Wu J, Ou B . Deep Learning-Based Radiomics of B-Mode Ultrasonography and Shear-Wave Elastography: Improved Performance in Breast Mass Classification. Front Oncol. 2020; 10:1621. PMC: 7485397. DOI: 10.3389/fonc.2020.01621. View

Fujioka T, Katsuta L, Kubota K, Mori M, Kikuchi Y, Kato A . Classification of Breast Masses on Ultrasound Shear Wave Elastography using Convolutional Neural Networks. Ultrason Imaging. 2020; 42(4-5):213-220. DOI: 10.1177/0161734620932609. View

Li J, Cao Y, Zhao Z, Shi Z, Duan X, Chang C . Prediction for pathological and immunohistochemical characteristics of triple-negative invasive breast carcinomas: the performance comparison between quantitative and qualitative sonographic feature analysis. Eur Radiol. 2021; 32(3):1590-1600. DOI: 10.1007/s00330-021-08224-x. View

10.

Zheng X, Yao Z, Huang Y, Yu Y, Wang Y, Liu Y . Deep learning radiomics can predict axillary lymph node status in early-stage breast cancer. Nat Commun. 2020; 11(1):1236. PMC: 7060275. DOI: 10.1038/s41467-020-15027-z. View

11.

Galati F, Moffa G, Pediconi F . Breast imaging: Beyond the detection. Eur J Radiol. 2021; 146:110051. DOI: 10.1016/j.ejrad.2021.110051. View

12.

Shen Y, E Shamout F, Oliver J, Witowski J, Kannan K, Park J . Artificial intelligence system reduces false-positive findings in the interpretation of breast ultrasound exams. Nat Commun. 2021; 12(1):5645. PMC: 8463596. DOI: 10.1038/s41467-021-26023-2. View

13.

Sannachi L, Tadayyon H, Sadeghi-Naini A, Tran W, Gandhi S, Wright F . Non-invasive evaluation of breast cancer response to chemotherapy using quantitative ultrasonic backscatter parameters. Med Image Anal. 2014; 20(1):224-36. DOI: 10.1016/j.media.2014.11.009. View

14.

Wang X, Cui L, Feng J, Chen W . Artificial intelligence for breast ultrasound: An adjunct tool to reduce excessive lesion biopsy. Eur J Radiol. 2021; 138:109624. DOI: 10.1016/j.ejrad.2021.109624. View

15.

Sannachi L, Gangeh M, Tadayyon H, Gandhi S, Wright F, Slodkowska E . Breast Cancer Treatment Response Monitoring Using Quantitative Ultrasound and Texture Analysis: Comparative Analysis of Analytical Models. Transl Oncol. 2019; 12(10):1271-1281. PMC: 6639683. DOI: 10.1016/j.tranon.2019.06.004. View

16.

Li J, Bu Y, Lu S, Pang H, Luo C, Liu Y . Development of a Deep Learning-Based Model for Diagnosing Breast Nodules With Ultrasound. J Ultrasound Med. 2020; 40(3):513-520. DOI: 10.1002/jum.15427. View

17.

Jiang M, Li C, Luo X, Chuan Z, Chen R, Tang S . Radiomics model based on shear-wave elastography in the assessment of axillary lymph node status in early-stage breast cancer. Eur Radiol. 2021; 32(4):2313-2325. DOI: 10.1007/s00330-021-08330-w. View

18.

Niu S, Huang J, Li J, Liu X, Wang D, Zhang R . Application of ultrasound artificial intelligence in the differential diagnosis between benign and malignant breast lesions of BI-RADS 4A. BMC Cancer. 2020; 20(1):959. PMC: 7532640. DOI: 10.1186/s12885-020-07413-z. View

19.

Goetz M, Gradishar W, Anderson B, Abraham J, Aft R, Allison K . NCCN Guidelines Insights: Breast Cancer, Version 3.2018. J Natl Compr Canc Netw. 2019; 17(2):118-126. DOI: 10.6004/jnccn.2019.0009. View

20.

Dialani V, Chadashvili T, Slanetz P . Role of imaging in neoadjuvant therapy for breast cancer. Ann Surg Oncol. 2015; 22(5):1416-24. DOI: 10.1245/s10434-015-4403-9. View